Cografting of carotid body cells improves the long-term survival, fiber outgrowth and functional effects of grafted dopaminergic neurons. (May 2012)

• Record Type: Journal Article
• Authors: Rodriguez-Pallares, Jannette; Joglar, Belen; Muñoz-Manchado, Ana B; Villadiego, Javier; Toledo-Aral, Juan J; Labandeira-Garcia, Jose L
• Is Part Of: Regenerative medicine. Volume 7:Number 3(2012)
• Page Start: 309
• Page End: 322
• Publication Date: 2012-05
• Subjects: carotid body -- cell therapy -- dopamine -- GDNF -- neuroprotection -- Parkinson -- rat -- transplantation; Cellular therapy -- Periodicals; Stem cells -- Transplantation -- Periodicals; Degeneration (Pathology) -- Treatment -- Periodicals; Regeneration (Biology) -- Periodicals; 611.018
• DOI: 10.2217/rme.12.22
• Languages: English
• ISSNs: 1746-0751

Abstract

Aims: A major limiting factor for cell therapy in Parkinson's disease is that the survival of grafted dopaminergic neurons is very poor, which may be improved by administration of GDNF, for which the carotid body is a good source.Materials & methods: Rats with total unilateral dopaminergic denervation were grafted with a cell suspension of rat dopaminergic neuroblasts with or without cell aggregates from the rat carotid body. At 1, 2 and 3 months after grafting, the rats were tested in the cylinder and the rotometer and killed 4 months after grafting.Results: We observed that the survival of dopaminergic neurons and graft-derived dopaminergic innervation were higher in rats that received mixed grafts. Both grafted groups showed complete recovery in the amphetamine-induced rotation test. However, rats with cografts performed significantly better in the cylinder test.Conclusion: Cografting of carotid body cells may constitute a useful strategy for cell therapy in Parkinson's disease.